Sergio Barajas, BS^1,2, Sisi Chen, PhD^3*, Sasidhar Vemula^2*, Yuxia Yang^2*, Edward Simpson^2*, Wenjie Cai, MS^1,2, Shiyu Xiao, MS¹, Hongxia Chen, MD/PhD^1*, Stephanie Halene, MD⁴, Madina Sukhanova^1*, Yunlong Liu, PhD^2*, Omar Abdel-Wahab, MD⁵ and Yan Liu, PhD¹

¹Northwestern University, Chicago, IL
²Indiana University, Indianapolis, IN
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Section of Hematology, Yale Univ. School of Medicine, New Haven, CT
⁵Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY

Maiko Sezaki, PhD^1*, Michihiro Hashimoto, PhD^1*, Asumi Yokota, PhD^2*, Nathan Salomonis, PhD^3*, H. Leighton Grimes, PhD⁴ and Gang Huang, PhD^1,5

¹Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX
²Laboratory of Stem Cell Regulation, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan
³Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁴Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁵Department of Pathology and Laboratory Medicine, UT Health San Antonio, San Antonio, TX

Prabhjot Kaur, PhD^1*, Cassandra Berntsen^2*, James Leonard^2*, Daniil Shabashvili^2*, Qingchen Yuan, MBBS², Bowen Yan, PhD^2*, Richard Lynn Bennett, PhD², Alberto Riva, PhD^3*, Jonathan D. Licht, MD² and Olga A. Guryanova, MD, PhD⁴

¹Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL
²University of Florida, Gainesville, FL
³ICBR Bioinformatics, Cancer and Genetic Research Complex, University of Florida, Gainesville, FL
⁴Department of Pharmacology and therapeutics, University of Florida College of Medicine, Gainesville, FL

Julien Legrand, PhD student^1*, Hakim Ouled-Haddou^2*, Stefan Djordjevic^3*, Thanina Bouzidi^1*, Cathy Gomila^4*, Loïc Garçon^5,6,7* and Etienne Paubelle^8*

¹Laboratoire Hématim UR4666 CURS-UPJV, CHU Amiens Picardie, Amiens, France
²Université Picardie Jules Verne, Amiens, France, FRA
³UR 4666, Université Picardie Jules Verne, Amiens, France
⁴EA 4666, HEMATIM, Université De Picardie Jules Verne, Amiens, FRA
⁵Laboratory of Hematology, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
⁶HEMATIM EA4666, Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France
⁷Laboratoire d'Hématologie, CHU Amiens, Le Kremlin Bicêtre, France
⁸Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, FRA

Yang Jo Chung, PhD^1,2, Anthony Wokasch, MS^3*, Masahiro Onozawa, M.D., Ph.D.⁴ and Peter D. Aplan, MD^1,5

¹NIH, NCI, CCR, Bethesda, MD
²Myeloid Malignancies Program, National Institutes of Health, Myeloid Malignancies Program, National Institutes of Health
³NIH, NCI, CCR, Genetics Branch, Bethesda, MD
⁴Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
⁵Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD

David Rombaut^1*, Tobias Tekath^2*, Sarah Sandmann, PhD^3*, Simon Crouch, PhD^4*, Aniek O. de Graaf, PhD^5*, Olivier Kosmider, PharmD, PhD^6*, Magnus Tobiasson, MD^7*, Andreas Lennartsson^8*, Bert A. Van der Reijden, PhD⁹, Sophie Park, MD, PhD¹⁰, Maud D'Aveni^11*, Bohrane Slama^12*, Emmanuelle Clappier, Pharm.D., Ph.D.^13*, Pierre Fenaux, MD, PhD¹⁴, Lionel Ades, MD, PhD¹⁴, Arjan A. van de Loosdrecht, MD, PhD¹⁵, Saskia MC Langemeijer, MD, PhD^16*, Argiris S. Symeonidis, MD, PhD¹⁷, Jaroslav Čermák, MD, PhD¹⁸, Claude Preudhomme, PharmD, PhD^19*, Aleksandar Savic, MD, PhD^20*, Ulrich Germing^21*, Reinhard Stauder, MD, MSc²², David T. Bowen, MD, PhD^23*, Corine J. Van Marrewijk^24*, Elsa Bernard, PhD^25*, Alexandra Smith, PhD^4*, Daniel Painter, BSc^4*, Theo J.M. de Witte, MD, PhD²⁶, Eva Hellstrom Lindberg, MD, PhD^7*, Julian Varghese^27*, Martin Dugas^28*, Joost H.A. Martens^29*, Luca Malcovati, MD³⁰, Joop H. Jansen, PhD^31* and Michaela Fontenay^1*

¹Laboratory of Hematology, Université Paris Cité, Institut Cochin, INSERM U1016, CNRS UMR8104; Assistance Publique-Hôpitaux de Paris Centre, Hôpital Cochin, Paris, FRA
²Institute of Medical Informatics, University of Muenster, Münster, DEU
³Institute of Medical Informatics, University of Muenster, Muenster, DEU
⁴Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, GBR
⁵Department of Laboratory Medicine, Laboratory of Hematology, Radboud university medical center, Nijmegen, Netherlands
⁶Laboratory of Hematology, Université Paris Cité and Assistance Publique-Hôpitaux de Paris. Centre, Hôpital Cochin, Paris, France
⁷Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm, SWE
⁸Department of Biosciences and Nutrition, Karolinska Institute, Huddinge, SWE
⁹Department of Laboratory Medicine, Laboratory of Hematology, Radboud university medical centre, Nijmegen, GL, Netherlands
¹⁰Clinique Universitaire d’hématologie, Université de Grenoble-Alpes, CHU de Grenoble, Grenoble, France
¹¹Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Vandoeuvre-les-Nancy, France
¹²Service d'onco-hématologie, Centre Hospitalier Général d'Avignon, Avignon, FRA
¹³Laboratoire d'Hématologie, Université Paris Cité, Assistance Publique des Hôpitaux de Paris Nord, Hôpital Saint-Louis, Paris, France
¹⁴Hématologie Seniors, Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, France
¹⁵Department of Hematology, Amsterdam UMC, location VUmc, CCA, Amsterdam, Netherlands
¹⁶Department of Hematology, Radboud university medical center, Nijmegen, Netherlands
¹⁷Hematology Division, Department of Internal Medicine, University of Patras, Medical School, Patras, GRC
¹⁸Institute of Hematology and Blood Transfusion, Prague, Czech Republic
¹⁹Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France
²⁰Clinic of Hematology, Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, SRB
²¹Department of Hematology, Oncology and Clinical Immunology, Universitatsklinik Dusseldorf, Dusseldorf, Germany
²²Department of Internal Medicine V (Haematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, AUT
²³St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, GBR
²⁴Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
²⁵Gustave Roussy, université Paris-Saclay, Inserm U981, Villejuif, France
²⁶Department of Tumor Immunology, Radboud Institute of Molecular Life Sciences, Radboud university medical centre, Nijmegen, NLD
²⁷Institute of Medical Informatics, University of Münster, Münster, Germany
²⁸Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany
²⁹Faculty of Science, Department of Molecular Biology, Radboud University, Nijmegen, Netherlands
³⁰Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia & S. Matteo Hospital, Pavia, Italy
³¹Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands

Ioannis Mitroulis^1*, Athanasios Tasis^2*, Maria Grigoriou^2*, Nikolaos Papaioannou^3*, Nikolaos Paschalidis^3*, Katerina Loukogiannaki^3*, Anastasia Filia^4*, Kyriaki Katsiki^2*, Eleftheria Lamprianidou, PhD^2*, Konstantinos Liapis, MD, PhD⁵, Themis Alissafi^3* and Ioannis Kotsianidis, MD, PhD⁶

¹Democritus University of Thrace, Alexandroupolis, Greece
²Department of Hematology, Democritus University of Thrace, Alexandroupolis, Greece
³Biomedical Research Foundation Academy of Athens, Athens, Greece
⁴BRFAA, Athens, GRC
⁵Democritus University of Thrace, Alexandroupolis, GRC
⁶Democritus University of Thrace Medical School, Alexandroupoli, Greece

Nandini Ramachandra, MS^1*, Charan Thej Reddy Vegivinti, MD, MBBS², Srabani Sahu^1*, Bianca Rivera, PhD^3*, Sarah Aminov, MSc¹, Ariel Fromowitz, MD¹, Jinghang Zhang, MD^4*, Fnu Aodengtuya^4*, Kith Pradhan, PhD^1*, Rongbao Zhao, PhD^3*, Leya Schwartz, MD³, Victor Thiruthuvanathan, MS^4*, Rahul Sanawar, PhD^3*, Emma Rabinovich, MD¹, Opeyemi Ajibade, MD, MS^1*, Aditi Shastri, MD¹, Michael Lahn^5* and Amit K. Verma, MD⁶

¹Montefiore Einstein Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
²Department of Medicine, Jacobi Medical Center / Albert Einstein College of Medicine, Bronx, NY
³Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
⁴Albert Einstein College of Medicine, Bronx, NY
⁵iOnctura SA, Geneva, Switzerland
⁶Department of Oncology, Albert Einstein College of Medicine, New York, NY

Ahmad Nanaa, MD^1,2, Aref Al-Kali, MD^3,4, Dragan Jevremovic, MD, PhD^5*, Phuong L. Nguyen, MD⁴, Patricia Greipp, DO⁵, Rong He, MD⁵, Mrinal M. Patnaik, MD, MBBS³, Abhishek A Mangaonkar, MBBS⁴, Hassan Alkhateeb, MD^3*, Julia Anderson^6*, Weina Chen^7*, Olga Weinberg^8*, Stephen Chung, M.D.⁹ and Yazan F. Madanat, MD¹⁰

¹Mayo Clinic, ROCHESTER, MN
²John H. Stroger, Jr. Hospital of Cook County, Chicago, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN
⁵Division of Hematopathology, Mayo Clinic, Rochester, MN
⁶Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁷Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX
⁸UT Southwestern, Dallas
⁹Division of Hematology/Oncology, Department of Internal Medicine, Children's Research Institute, University of Texas Southwestern, Dallas, TX
¹⁰Hematologic Malignancies and Cellular Therapy, University of Texas Southwestern Medical Center, Dallas, TX

Rami S. Komrokji, MD¹, Manuel Ugidos Guerrero^2*, Guillermo Garcia-Manero, MD³, Amer M. Zeidan, MBBS, MHS⁴, Uwe Platzbecker, MD⁵, Sheida Hayati^6* and Sadanand Vodala^7*

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²BMS Center For Innovation and Translational Research Europe (CITRE), Seville, Spain
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
⁵Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
⁶Informatics and Predictive Sciences, Bristol Myers Squibb, Princeton, NJ
⁷Hematology, Translational Medicine and Disease Team, Bristol Myers Squibb, Summit, NJ

Nicolas Bonadies, MD^1,2,3, Vladislav Grigorjev, PhD^4,5*, Naomi Porret, PhD¹, Keith Harshman, PhD^6*, Linda L Grob, PhD^4,5*, Tata Nageswara Rao, PhD^7,8*, Lina Al Tai^1*, Rosanna Rubin^1*, Helen Broughton^1*, Sandra Goetze, PhD^9,10*, Nora C Toussaint, PhD^4,5* and Stefan Balabanov, MD, PhD^11*

¹Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
²Department for BioMedical Research, University of Bern, Bern, Switzerland
³Oncology/Hematology Practice Solothurn/Bern, Solothurn, Switzerland
⁴NEXUS Personalized Health Technologies, Swiss Federal Institute of Technology Zurich (ETHZ), Zurich, Switzerland
⁵Swiss Institute of Bioinformatics, Zurich, Switzerland
⁶Health 2030 Genome Center, University of Lausanne, Lausanne, Switzerland
⁷Department of Oncology and Hematology, Kantonsspital St Gallen, St. Gallen, Switzerland
⁸Institute for Pharmacology, University of Bern, Bern, Switzerland
⁹Department of Health Sciences and Technology (D-HEST), Swiss Federal Institute of Technology Zurich (ETHZ), Zurich, Switzerland
¹⁰Personalized Health and Related Technologies (PHRT) Swiss Multi-Omics Center (SMOC), Swiss Federal Institute of Technology Zurich (ETHZ), Zurich, Switzerland
¹¹Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zürich, Switzerland

Oriol Calvete^1*, Rashmi Kanagal-Shamanna, MD², Julia Mestre^1*, Guillermo Montalban-Bravo, MD³, Courtney D. DiNardo, MD, MSc³, Koji Sasaki, MD³, Jessica Aranda^4*, Pamela Acha^1*, Blanca Xicoy, MD^5,6*, Ana Pérez González, MD^7*, Laura Palomo, PhD^8*, Maria Julia Montoro, MD, PhD^8*, Mireia Margeli, MD^9* and Francesc Sole, PhD¹

¹Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
²Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Samples Circuit, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
⁵Myeloid Neoplasm Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
⁶Haematology Department, Hospital Germans Trias i Pujol-Catalan Institute of Oncology., Badalona, Spain
⁷Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebrón, Barcelona, Spain
⁸Experimental Hematology. Hematology Department Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebrón, Barcelona, Spain
⁹Medical Oncology Department, Catalan Institute of Oncology. Badalona Applied Research group in Oncology (B-ARGO). Germans Trias i Pujol Research Institute, Badalona, Spain